解读KRAS激活中的全oster机制:从GTP诱导的构造动态和相互作用网络重组的洞察力
De-Rui Zhao1,2,3, Ji-Tong Yang4, Meng-Ting Liu1,2
1College of Agriculture and Biological Science, Dali University Dali 671000 China ylqbioinfo@gmail.com speng431@163.com.
RSC advances
|January 24, 2025
概括
结合GTP增强了KRAS蛋白的灵活性,并促进了其活性构造,揭示了针对癌症治疗药物开发的关键全性途径.
科学领域:
- 分子生物学分子生物学
- 计算生物物理学的计算生物物理.
- 癌症研究 癌症研究
背景情况:
- 克拉斯蛋白的动态和激活对于癌症治疗至关重要.
- 通过GTP激活KRAS的精确分子机制仍然不完全理解.
研究的目的:
- 研究GTP/GDP交换对KRAS热力学和运动性质的影响.
- 使用先进的计算方法阐明KRAS激活机制.
主要方法:
- 分子动力学 (MD) 模拟来分析形状变化.
- 马尔科夫状态模型 (MSM) 用于研究状态过渡.
- 神经关系推理 (NRI) 模型用于评估蛋白质相互作用.
- 基于图形的最短路径分析,以确定全性路径.
主要成果:
- 结合GTP显著增加了KRAS的结构灵活性,有利于具有开放开关区域的活性状态.
- GTP-bound状态更有效地过渡到活动状态,而不是GDP-bound状态.
- 结合GTP增强了KRAS的残留物-残留物相互作用,特别是长距离的相互作用.
- 确定了参与KRAS激活的体信号通路和关键氨基酸位点.
结论:
- 通过增强灵活性和相互作用,GTP结合会诱导KRAS的全激活.
- 鉴定的途径为开发针对癌症KRAS活性的药物提供了洞察力.
更多相关视频
相关概念视频
Allosteric Regulation
57.5K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.5K
Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K


